Comparison of the different doses of vancomycin on plasma concentration of the drug in patients hospitalized in IC

Phase 2

Recruiting

• Conditions: Condition 1: Meningitis. Condition 2: Endocarditis. Condition 3: Sepsis. Condition 4: Osteomyelitis.; Bacterial meningitis, not elsewhere classified; Acute and subacute endocarditis; Sepsis, unspecified; Osteomyelitis

• Registration Number: IRCT201710109014N194
• Lead Sponsor: Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Age of 18 to 60 years; meningitis or endocarditis or sepsis or osteomyelitis with positive culture for staph or enterococci resistant to methicillin.
Exclusion criteria: Hypersensitivity to vancomycin; renal toxicity; using aminoglycoside drugs concurrently.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measuring plasma concentration of vancomycin. Timepoint: 2 months after treatment. Method of measurement: Through High Performance Liquid Chromatography.